Oncofinder, a new method for the analysis of intracellular signaling pathway activation using transcriptomic data

Anton A Buzdin1, Alex A Zhavoronkov2, Mikhail B Korzinkin3

  • 1Pathway Pharmaceuticals, Limited Wan Chai, Hong Kong, Hong Kong ; D. Rogachev Federal Research Center of Pediatric Hematology, Oncology and Immunology Moscow, Russia ; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry Moscow, Russia ; Biological and Medical Physics, Moscow Institute of Physics and Technology Dolgoprudny, Russia.

Frontiers in Genetics
|April 12, 2014
PubMed

Insights

OncoFinder is a novel biomathematical method for analyzing intracellular signaling pathway activation (SPA). It distinguishes gene product roles and assesses their importance, offering a universal tool for various biological conditions.

Area of Science:

  • Biomathematics
  • Molecular Biology
  • Systems Biology

Background:

  • Intracellular signaling pathway activation (SPA) is crucial for understanding cellular responses.
  • Existing methods for analyzing gene expression data have limitations in distinguishing gene product roles.
  • Accurate assessment of SPA is vital for studying physiological, stress, and malignancy conditions.

Purpose of the Study:

  • To introduce OncoFinder, a universal biomathematical method for quantitative and qualitative SPA analysis.
  • To differentiate the positive/activator and negative/repressor roles of gene products within signaling pathways.
  • To enable the assessment of individual gene product importance in pathway activation.

Main Methods:

  • Development of a novel biomathematical approach, OncoFinder.
  • Utilizing kinetic models to assess the relative importance of gene products based on protein interactions.
  • Proposing a method to distinguish between positive and negative regulatory roles of genes in pathways.

Main Results:

  • OncoFinder provides a universal framework for SPA analysis applicable to diverse biological states.
  • The method accounts for the distinct roles (activator/repressor) of gene products.
  • Simplified SPA evaluation formulas are applicable even when gene product importance factors are unknown.

Conclusions:

  • OncoFinder offers a versatile and powerful tool for researchers studying signaling pathways.
  • The method's ability to differentiate gene product roles enhances the accuracy of SPA analysis.
  • Widespread adoption of OncoFinder is anticipated due to its broad applicability and potential to advance molecular-level research.